Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

PURPOSE: Cure rates for localized high-risk prostate cancers (PCa) and some intermediate-risk PCa are frequently suboptimal with local therapy. Outcomes are improved by concomitant androgen-deprivation therapy (ADT) with radiation therapy, but not by concomitant ADT with surgery. Luteinizing hormone...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Oncol
Main Authors: Taplin, Mary-Ellen, Montgomery, Bruce, Logothetis, Christopher J., Bubley, Glenn J., Richie, Jerome P., Dalkin, Bruce L., Sanda, Martin G., Davis, John W., Loda, Massimo, True, Lawrence D., Troncoso, Patricia, Ye, Huihui, Lis, Rosina T., Marck, Brett T., Matsumoto, Alvin M., Balk, Steven P., Mostaghel, Elahe A., Penning, Trevor M., Nelson, Peter S., Xie, Wanling, Jiang, Zhenyang, Haqq, Christopher M., Tamae, Daniel, Tran, NamPhuong, Peng, Weimin, Kheoh, Thian, Molina, Arturo, Kantoff, Philip W.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2014
נושאים:
ORIGINAL REPORTS
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226804/
https://ncbi.nlm.nih.gov/pubmed/25311217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.53.4578
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים